CSBR:NASDAQ
Champions Oncology Inc
US$4,75
arrow_downward
-1,86%(-0,090) 1D
10 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,82
High
US$4,88
Low
US$4,75
Mkt. cap
66,11 ລ້ານ
Avg. vol.
9,19 ພັນ
Volume
8,60 ພັນ
52-wk high
US$8,31
52-wk low
US$4,63
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,82
High
US$4,88
Low
US$4,75
Mkt. cap
66,11 ລ້ານ
Avg. vol.
9,19 ພັນ
Volume
8,60 ພັນ
52-wk high
US$8,31
52-wk low
US$4,63
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
investingLive
·
1 ຊົ່ວໂມງກ່ອນ
UBS keeps 8,900 S&P 500 target for end-2027, says 20% derating sets up strong gains
Investing.com
·
3 ຊົ່ວໂມງກ່ອນ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.30%
The Motley Fool
·
2 ຊົ່ວໂມງກ່ອນ
Only 2 Novembers Since 1950 Have Started Worse for the S&P 500 Than This One. Here's What Followed the Other Weak Starts.
ChartMill
·
4 ຊົ່ວໂມງກ່ອນ
S&P 500 Top Gainers and Losers for Today's Session
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com